SYNOVIAL SARCOMA
Clinical trials for SYNOVIAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMA trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug access extended for cancer patients who responded well
Disease control CompletedThis study offers continued access to the drug tazemetostat for 58 people with certain cancers who previously benefited from it in other trials. The main goal is to track long-term safety and how long participants stay on the drug. It is not a cure but helps control the disease.
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Scientists hunt for clues to predict sarcoma drug success
Knowledge-focused CompletedThis study aimed to find biological markers that could predict how well the drug trabectedin works in people with certain advanced soft-tissue sarcomas. Researchers collected tumor samples and blood from 29 adults before and during treatment to look for patterns. The goal was to …
Matched conditions: SYNOVIAL SARCOMA
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC